The following Management's Discussion and Analysis of Financial Condition and
Results of Operations is intended to provide information necessary to understand
our audited consolidated financial... | April 12, 2023

Related Keywords

California ,United States ,Delaware ,Germany ,Tennessee , ,Burning Rock Biotech Limited ,Like Pharma Services ,Centers For Medicare ,Company Razor ,Oncocyte Corporation ,Nasdaq ,Silicon Valley Bank ,Pharma Services ,Medicaid Services ,Razor Genomics Inc ,Company Own Stock ,Dragon Scientific ,Financial Condition ,Nasdaq Notice ,Nasdaq Listing Rule ,Nasdaq Capital Market ,Nasdaq Global Market ,Nasdaq Capital ,Stock Purchase Agreement ,Stock Purchase ,Genomics Inc ,Razor Stock Purchase Agreement Oncocyte ,Razor Stock Purchase Agreement ,Razor Sale ,Razor Closing ,Accounting Estimates ,Accounting Standard Codification ,Accounting Standards Codification ,Business Combinations ,Certain Financial Instruments ,Derivative Financial Instruments Indexed ,Potentially Settled ,Staff Accounting Bulletin ,Income Taxes ,Because Determarx ,Medicare Advantage ,Year Ended ,Initial Milestone Payments ,Exclusive Sublicense Agreement ,Rock Biotech Limited ,Operating Summary ,Net Revenue ,Sale Razor Genomics ,Valley Bank ,Preferred Stock ,Underwritten Offering ,Edgar Online ,Oncocyte Corporation Stock Exchange ,News ,Information ,Press Release ,The ,Following ,Discussion ,End ,Analysis ,F ,Financial ,Condition ,Operations ,Us ,Ntended ,O ,Rovide ,Necessary ,Udited ,Onsolidated Ocx Us68235c1071 ,